| Literature DB >> 28662724 |
Kai Dang1, Stephen L Doggett2, G Veera Singham3, Chow-Yang Lee4.
Abstract
The worldwide resurgence of bed bugs [both Cimex lectularius L. and Cimex hemipterus (F.)] over the past two decades is believed in large part to be due to the development of insecticide resistance. The transcriptomic and genomic studies since 2010, as well as morphological, biochemical and behavioral studies, have helped insecticide resistance research on bed bugs. Multiple resistance mechanisms, including penetration resistance through thickening or remodelling of the cuticle, metabolic resistance by increased activities of detoxification enzymes (e.g. cytochrome P450 monooxygenases and esterases), and knockdown resistance by kdr mutations, have been experimentally identified as conferring insecticide resistance in bed bugs. Other candidate resistance mechanisms, including behavioral resistance, some types of physiological resistance (e.g. increasing activities of esterases by point mutations, glutathione S-transferase, target site insensitivity including altered AChEs, GABA receptor insensitivity and altered nAChRs), symbiont-mediated resistance and other potential, yet undiscovered mechanisms may exist. This article reviews recent studies of resistance mechanisms and the genes governing insecticide resistance, potential candidate resistance mechanisms, and methods of monitoring insecticide resistance in bed bugs. This article provides an insight into the knowledge essential for the development of both insecticide resistance management (IRM) and integrated pest management (IPM) strategies for successful bed bug management.Entities:
Keywords: Bed bug; Cimex hemipterus; Cimex lectularius; Insecticide resistance; Mechanism; Molecular basis; Resistance monitoring
Mesh:
Substances:
Year: 2017 PMID: 28662724 PMCID: PMC5492349 DOI: 10.1186/s13071-017-2232-3
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Progress in morphological, behavioral, biochemical, bioassay, and genetic characterization of insecticide resistance mechanisms in bed bugs (Cimex spp.)
| Year | Characterization | Targets | Methods | Accession numbera | Resistance mechanisms | Reference |
|---|---|---|---|---|---|---|
|
| ||||||
| 2009 | Behavioral | – | Bioassay: SC | – | Behavioral resistance | [ |
| 2009; 2015;2016 | Bioassay | P450s; esterases | Bioassay (SC/T) plus synergists (e.g. PBO, PBH, EN16/5–1) | Metabolic resistance: P450s, esterases | [ | |
| 2008; 2011; 2016 | Biochemical | P450s; GSTs; esterases | Biochemical assays | – | Metabolic resistance: P450s, GSTs and esterases | [ |
| 2016 | Morphological | Cuticle | SEM | – | Penetration resistance | [ |
| 2008 | Genetic | VGSC | Cloning and sequencing (RACE) | FJ031996; FJ031997 | Target site insensitivity: | [ |
| 2011 | Genetic | Transcriptome | 454 pyrosequencing (Roche 454 GS FLX Titanium platform) | SRA024509 | Metabolic resistance: P450s | [ |
| 2011 | Genetic | Transcriptome | High-throughput sequencing (Roche 454 Titanium platform) | SRA043735 | Metabolic resistance: P450s, GSTs and esterases; Target site insensitivity: | [ |
| 2012 | Genetic | RNA-seq | Illumina high-throughput sequencing (GAII platform) | GSE31823 | Metabolic resistance: P450s, GSTs, ABC-transporters, esterases; Penetration resistance; Target site insensitivity: | [ |
| 2012 | Genetic | ClCPR | Cloning and sequencing (RACE) | JQ178363 | Metabolic resistance: P450s | [ |
| 2012 | Genetic | ClAChE1; ClAChE2; ClSChE | Cloning and sequencing (RACE) | JN563927; GU597837;GU597838;GU597839 | – | [ |
| 2013 | Genetic | CPRR | Data from NCBI | – | Penetration resistance | [ |
| 2013 | Genetic | Transcriptome | 454 pyrosequencing (Roche 454 GS FLX Titanium platform) | – | Metabolic resistance: P450s, esterases, ABC-transporters; Penetration resistance; Target site insensitivity: | [ |
| 2016 | Genetic | Genome | Illumina high-throughput sequencing (Illumina HiSeq2000s) | SRS580017 | Metabolic resistance: P450s, esterases, ABC-transporters, GSTs; Penetration resistance; Target site insensitivity: | [ |
| 2016 | Genetic | Genome; RNA-seq | Illumina high-throughput sequencing | SRS749263; SRR1790655 | Target site insensitivity: | [ |
|
| ||||||
| 2011 | Bioassay | P450s | Bioassay (SC) plus PBO | – | Metabolic resistance: P450s | [ |
| 2007 | Biochemical | P450s; GSTs; Esterases | Biochemical assays | – | Metabolic resistance: GSTs, and esterases | [ |
| 2015 | Genetic | VGSC(Part) | Sanger sequencing | – | Target site insensitivity: | [ |
Abbreviations: EN16/5–1 6-[2-(2-butoxyethoxy) ethoxymethyl]-5-propyl-2, 3-dihydrobenzofuranby [127], PBH 3-Phenoxybenzyl hexanoate, a surrogate substrate for carboxylesterases and oxidases [136], SC surface contact, T topical application, SEM scanning electron microscope, ClCPR Cimex lectularius NADPH-cytochrome P450 reductase [122], CPRR cuticular protein with the rebers and riddiford consensus [94], ClAChE1, ClAChE2 two C. lectularius acetylcholinesterases, ClSChE C. lectularius salivary gland-specific cholinesterase-like protein [168], RACE rapid amplification of cDNA ends, ABC-transporters ATP-binding cassette (ABC) transporters
aData from GenBank at NCBI (National Center for Biotechnology Information)
Reports of bed bug (Cimex spp.) resurgence from around the world since the beginning of the 21th century
| Continent | Country | Species | Reference |
|---|---|---|---|
| Asia | One of the Arabian Gulf States |
| [ |
| Bangladesh |
| [ | |
| China (Mainland) |
| [ | |
| Taiwan |
| [ | |
| India |
| [ | |
| Iran |
| [ | |
| Israel |
| [ | |
| Japan |
| [ | |
| Kuwait |
| [ | |
| Malaysia |
| [ | |
| Pakistan |
| [ | |
| Singapore |
| [ | |
| South Korea |
| [ | |
| Sri Lanka |
| [ | |
| Thailand |
| [ | |
| Africa | Ethiopia |
| [ |
| Kenya |
| [ | |
| Nigeria |
| [ | |
| Rwanda |
| [ | |
| Sierra Leone |
| [ | |
| South Africa |
| [ | |
| Tanzania |
| [ | |
| Uganda |
| [ | |
| Americas | Argentina |
| [ |
| Brazil |
| [ | |
| Canada |
| [ | |
| Chile |
| [ | |
| Colombia |
| [ | |
| Cuba |
| [ | |
| Mexico |
| [ | |
| Panama |
| [ | |
| Peru |
| [ | |
| USA |
| [ | |
| Venezuela |
| [ | |
| Europe | Austria |
| [ |
| Czech Republic |
| [ | |
| Denmark |
| [ | |
| France |
| [ | |
| Germany |
| [ | |
| Hungary |
| [ | |
| Italy |
| [ | |
| Norway |
| [ | |
| Poland |
| [ | |
| Spain |
| [ | |
| Russia |
| [ | |
| Sweden |
| [ | |
| Slovakia |
| [ | |
| Switzerland |
| [ | |
| UK |
| [ | |
| Oceania | Australia |
| [ |
| New Zealand |
| [ |
a Cimex spp., no indication of the species identification in the report
Reports of resistance to chlorinated hydrocarbons in bed bugs (Cimex spp.) by the 1970s
| Species | Year | Chlorinated hydrocarbon | Location | Reference |
|---|---|---|---|---|
|
| 1947 | DDT | USA (Hawaii) | [ |
| 1949 | DDT | Greece | [ | |
| 1952 | DDT | USA (Ohio, Illinois, Indiana, Utah) | [ | |
| 1953 | DDT | Belgian Congo | [ | |
| 1953 | DDT | Israel | [ | |
| 1953 | DDT | Japan, Italy | [ | |
| 1954 | HCH, dieldrin | Italy | [ | |
| 1955 | DDT | USA (Colorado, Pennsylvania, Texas) | [ | |
| 1956 | HCH, dieldrin | Israel | [ | |
| 1956 | DDT | French Guiana | [ | |
| 1956 | DDT | Iran | [ | |
| 1957 | γ-HCH | Israel | [ | |
| 1957 | DDT | Trinidad, Turkey | [ | |
| 1957 | DDT, chlordane, dieldrin | Italy | [ | |
| 1958 | Dieldrin, γ-HCH, aldrin, endrin, isodrin, α-chlordane, β-chlordane, methoxychlor, perthane, prolan | Israel | [ | |
| 1958 | DDT | Lebanon | [ | |
| 1958 | DDT | Japan, Korea, USA (Ohio, and two US naval vessels) | [ | |
| 1959 | DDT | Hungary, Poland | [ | |
| 1960 | HCH, dieldrin | Indonesia, Zambia, Rhodesia, Borneo | [ | |
| 1960 | DDT | Borneo, Indonesia, Colombia | [ | |
| 1960 | DDT | Zimbabwe | [ | |
| 1961 | DDT, HCH, dieldrin | South India | [ | |
| 1962 | γ-HCH | India | [ | |
| 1962 | DDT, HCH, dieldrin | South Africa | [ | |
| 1963 | DDT dieldrin | Gaza | [ | |
| 1967 | DDT, HCH, dieldrin | Egypt | [ | |
| 1971 | γ-HCH | Zambia, Italy, Borneo | [ | |
| 1972 | DDT | Papua-New Guinea | [ | |
| 1976 | DDT, dieldrin | Almost everywhere | [ | |
|
| 1955 | DDT | West India | [ |
| 1956 | HCH, dieldrin | West India | [ | |
| 1956 | DDT | Taiwan | [ | |
| 1956 | DDT | India (Bombay State) | [ | |
| 1957 | HCH, dieldrin | Tanzania, Kenya, Upper Volta | [ | |
| 1957 | DDT | Hong Kong, Singapore | [ | |
| 1957 | DDT | Kenya | [ | |
| 1957 | Dieldrin | Ivory Coast | [ | |
| 1958 | Dieldrin | Tanganyika | [ | |
| 1958 | DDT | Mombasa, Somalia, Gambia, Hong Kong | [ | |
| 1958 | Dieldrin | Mombasa, Gambia | [ | |
| 1958 | γ-HCH | Mombasa, Somalia, Gambia | [ | |
| 1958 | Methoxychlor | Mombasa, Somalia | [ | |
| 1959 | DDT | Poland | [ | |
| 1959 | HCH, dieldrin | Dahomeh, Zanzibar | [ | |
| 1960 | DDT | Malaysia, Thailand | [ | |
| 1960 | HCH, dieldrin | Malaysia | [ | |
| 1961 | DDT, HCH, dieldrin | Madagascar, South India | [ | |
| 1961 | DDT | Tanzania (Zanzibar) | [ | |
| 1962 | Dieldrin | Tanzania (Magugu) | [ | |
| 1970 | DDT | Papua-New Guinea | [ |
Abbreviations: HCH hexachlorocyclohexane, γ-HCH gamma-hexachlorocyclohexane, also known as lindane, gammaxene, gammallin and sometimes incorrectly called benzene hexachloride (BHC)
Published reports of insecticide resistance and product efficacy in modern bed bugs (Cimex spp.), post 2000
| Year | Insecticide | Method | Location/Strain | Susceptibility/efficacy | Resistance ratio | Reference |
|---|---|---|---|---|---|---|
|
| ||||||
| 2006 | α-cypermethrina | SC | UK (3 field strains) | Resistant | – | [ |
| 2006 | Bendiocarbb | SC | UK (3 field strains) | Resistant | – | [ |
| 2006 | Deltamethrina | SC | USA (Arlington, VA) | Resistant | >300 | [ |
| 2006 | Chlorfenapyrg | SC | Susceptible Harlan strain | Less effective | [ | |
| 2007 | Deltamethrina | SC | USA: Cincinnati, OH(CIN1, CIN2, CIN3); Lexington, KY (LEX1) | Resistant | >12,765 | [ |
| 2007 | λ-cyhalothrina | SC | USA (Cincinnati, OH[CIN1]) | Resistant | >6123 | [ |
| 2007 | Deltamethrina | SC | USA (Los Angeles, CA [LA2]; Kissimmee, FL[KIS1]; Vienna, VA[VIN1]) | Resistant | – | [ |
| 2007 | Deltamethrina | SC | USA (Los Angeles, CA [LA1]) | Susceptible | [ | |
| 2008 | Deltamethrina | SC | USA (New York City, NY [NY-BB]) | Resistant | >250 | [ |
| 2008 | Bifenthrina | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | λ-cyhalothrina | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | Permethrina | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | Carbarylb | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | Imidaclopridc | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | Fipronild | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Susceptible | [ | |
| 2008 | Diazinone | SC | USA (Arkansas: Washington, Lafayette) | Susceptible | [ | |
| 2008 | Diazinone | SC | USA (Arkansas: Carroll) | Resistant | – | [ |
| 2008 | Dichlorvose | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Resistant | – | [ |
| 2008 | Spinosadf | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Resistant | – | [ |
| 2008 | Chlorfenapyrg | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Less effective | [ | |
| 2008 | DDTh | SC | USA (Arkansas: Washington, Carroll, Lafayette) | Resistant | – | [ |
| 2008 | Chlorfenapyrg | SC | USA (Cincinnati, OH) | Less effective | [ | |
| 2009 | Pirimphos-methyle | T | Australia (Sydney strain) | Susceptible | 2.6 | [ |
| 2009 | Imidaclopridc | T | Australia (Sydney strain) | Susceptible | 2.6 | [ |
| 2009 | Bendiocarbb | T | Australia (Sydney strain) | Resistant | 250 | [ |
| 2009 | Deltamethrina | T | Australia (Sydney strain) | Resistant | 370,000 | [ |
| 2009 | Permethrina | T | Australia (Sydney strain) | Resistant | 1,235,000 | [ |
| 2009 | Diazinone | T/SC | Australia (Sydney strain) | Effective | [ | |
| 2009 | Pyrethrinsa | T/SC | Australia (Sydney strain) | Resistant | – | [ |
| 2009 | β-cyfluthrina | T/SC | Australia (Sydney strain) | Resistant | – | [ |
| 2009 | Tetramethrina | T/SC | Australia (Sydney strain) | Resistant | – | [ |
| 2009 | Deltamethrina | SC | USA (Cincinnati, OH [CIN-1]) | Resistant | >2588 | [ |
| 2009 | Deltamethrina | SC | USA (Worcester, MA[WOR-1]) | Resistant | >2588 | [ |
| 2010 | Deltamethrina | SC | USA (New York City, NY) | Resistant | >9375 | [ |
| 2010 | λ-cyhalothrina | SC | USA (New York City, NY) | Resistant | 6990 | [ |
| 2010 | Chlorfenapyrg | SC | USA (Cincinnati, OH [CIN-1]) | Effective | – | [ |
| 2010 | Chlorfenapyrg | SC | USA (Worcester, MA[WOR-1]) | Effective | – | [ |
| 2010 | Phenothrina | SC/T | Japan (four field strains) | Resistant | – | [ |
| 2010 | Permetrhina | SC/T | Japan (four field strains) | Resistant | – | [ |
| 2010 | Dichlorvose | SC/T | Japan (four field strains) | Susceptible | [ | |
| 2010 | Fenitrothione | SC/T | Japan (four field strains) | Susceptible | [ | |
| 2010 | Propoxurb | SC/T | Japan (four field strains) | Susceptible | [ | |
| 2010 | Deltamethrina | SC | USA (Cincinnati, OH; Lexington, KY; Troy, MI; Dover, NJ; Frankfort, KY; Kalamazoo, MI; Worcester, MA; Smithtown, Plainview, New York, NY) | Resistant | – | [ |
| 2011 | Deltamethrina | IT | USA (Richmond, VA) | Resistant | 5167 | [ |
| 2011 | β-cyfuthrina | IT | USA (Richmond, VA) | Resistant | 111 | [ |
| 2011 | Deltamethrina | SC | USA (Richmond, VA) | Resistant | 390.5 | [ |
| 2011 | Deltamethrina | SC | USA (Cincinnati, OH) | Resistant | >340 | [ |
| 2011 | Deltamethrina | SC | USA (Arlington, VA: Kramer) | Resistant | 339.6 | [ |
| 2011 | Permethrina | SC | USA (Arlington, VA: Kramer) | Resistant | >115.1 | [ |
| 2011 | Deltamethrina | SC | USA (Richmond, VA) | Resistant | 390.5 | [ |
| 2011 | Permethrina | SC | USA (Richmond, VA) | Resistant | >291.7 | [ |
| 2011 | DDTh | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Dieldrinh | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Bendiocarbb | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Propoxurb | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Malathione | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Fenitrothione | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Cyfluthrina | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Deltamethrina | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Permethrina | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | β-cyhalothrina | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Etofenproxa | SC | Thailand (Chiang Mai) | Resistant | – | [ |
| 2011 | Diazinone | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Fenobucarbb | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Esfenvaleratea | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Cypermethrina | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Bifenthrina | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Chlorfenapyrg | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Fipronild | Spray | Thailand (Chiang Mai) | Less effective | – | [ |
| 2011 | Imidaclopridc | Spray | Thailand (Chiang Mai) | Efficient | – | [ |
| 2011 | Permethrina | T, SC | Denmark | Resistant | – | [ |
| 2011 | Deltamethrina | SC | Denmark | Resistant | – | [ |
| 2011 | Chlorpyrifose | T, SC | Denmark | Effective | – | [ |
| 2012 | Deltamethrina | SC | USA (Columbus, OH) | Resistant | – | [ |
| 2012 | Pyrethrinsa | T | USA(New Haven, CT) | Resistant | – | [ |
| 2012 | Cyfluthrina | T | USA(New Haven, CT) | Resistant | – | [ |
| 2012 | λ-cyhalothrina | T | USA(New Haven, CT) | Resistant | – | [ |
| 2012 | cis-cypermethrina | T | USA(New Haven, CT) | Resistant | – | [ |
| 2012 | Deltamethrina | T | USA(New Haven, CT) | Resistant | – | [ |
| 2012 | Deltamethrina | T | USA (Cincinnati, OH [CIN-1], Plainview, NY [NY-1]) | Resistant | – | [ |
| 2012 | Neopynaminea | SC | France (Paris) | Resistant | – | [ |
| 2012 | Sumithrina | SC | France (Paris) | Resistant | – | [ |
| 2013 | Deltamethrina | SC | USA (CIN-1) | Resistant | 51 | [ |
| 2013 | Deltamethrina | SC | USA (CIN-1 S) | Resistant | 32,700,000 | [ |
| 2013 | Deltamethrina | SC | USA (NY-1) | Resistant | >300 | [ |
| 2013 | Deltamethrina | T | USA (Richmond, VA) | Resistant | >200,000 | [ |
| 2013 | β-cyfuthrina | T | USA (Richmond, VA) | Resistant | >160,000 | [ |
| 2014 | Deltamethrina | SC | Germany (Berlin) | Resistant | 3.8–5.1 | [ |
| 2014 | Deltamethrina | SC | USA: New York (Brooklyn) | Susceptible | – | [ |
| 2015 | Imidaclopridc/β-cyfluthrinc | SC | USA (Richmond and Epic Center strains) | Resistant | E: 3–5; | [ |
| 2015 | Acetamipridc/bifenthrina | SC | USA (Richmond and Epic Center strains) | Resistant | E: 39–1080; | [ |
| 2015 | Deltamethrina | SC | USA (Epic Center strain) | Resistant | 392 | [ |
| 2015 | d-allethrina | SC | Australia [NSW: Sydney (Abbotsford, Darlinghurst, North Parramatta, Northbridge, Redfern), Newcastle (Maryland); VIC: Melbourne (Ripponlea, South Yarra, Moonee Ponds), West Melbourne; WA: Perth (Cottesloe); NT: Alice springs; SA: Adelaide (Semaphore Park)] | Resistant | – | [ |
| 2016 | Imidaclopridc | T | USA (Jersey City, NJ) | Susceptible | 2.0 | [ |
| 2016 | Imidaclopridc | T | USA (Troy, MI) | Resistant | 462.6 | [ |
| 2016 | Imidaclopridc | T | USA (Cincinnati, OH) | Resistant | 163.3 | [ |
| 2016 | Acetamipridc | T | USA (Jersey City, NJ) | Resistant | 31.7 | [ |
| 2016 | Acetamipridc | T | USA (Troy, MI) | Resistant | >33,333 | [ |
| 2016 | Acetamipridc | T | USA (Cincinnati, OH) | Resistant | >33,333 | [ |
| 2016 | Thiamethoxamc | T | USA (Jersey City, NJ) | Susceptible | 2.4 | [ |
| 2016 | Thiamethoxamc | T | USA (Troy, MI) | Resistant | 546 | [ |
| 2016 | Thiamethoxamc | T | USA (Cincinnati, OH) | Resistant | 226.2 | [ |
| 2016 | Dinotefuranc | T | USA (Jersey City, NJ) | Resistant | 46.8 | [ |
| 2016 | Dinotefuranc | T | USA (Troy, MI) | Resistant | 198 | [ |
| 2016 | Dinotefuranc | T | USA (Cincinnati, OH) | Resistant | 358.6 | [ |
| 2016 | Deltamethrina | T | Australia: Parramatta(NSW), Alice Springs(NT) and Melbourne(VIC) | Resistant | – | [ |
| 2016 | Deltamethrina | SC | Australia (Parramatta[NSW]) | Resistant | – | [ |
|
| ||||||
| 2002 | α-cypermethrina | SC | Tanzania | Resistant | – | [ |
| 2002 | Permethrina | SC | Tanzania | Resistant | – | [ |
| 2007 | DDTh | SC | Sri Lanka | Resistant | – | [ |
| 2007 | Malathione | SC | Sri Lanka | Resistant | – | [ |
| 2007 | Propoxurb | SC | Sri Lanka | Resistant | – | [ |
| 2007 | Deltamethrine | SC | Sri Lanka | Resistant | – | [ |
| 2007 | Permethrine | SC | Sri Lanka | Resistant | – | [ |
| 2011 | λ-cyhalothrina | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Effective | – | [ |
| 2011 | Bifentrina | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Effective | – | [ |
| 2011 | Fenitrothione | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Effective | – | [ |
| 2011 | Fipronild | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Effective | – | [ |
| 2011 | Imidaclopridc | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Effective | – | [ |
| 2011 | DDTh | SC | Malaysia (Kmelayu14); Singapore (Serangoon) | Resistant | – | [ |
| 2011 | DDTh | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Dieldrinh | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Bendiocarbb | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Propoxurb | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Malathione | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Fenitrothione | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Cyfluthrina | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Deltamethrina | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Permethrina | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | λ-cyhalothrina | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Etofenproxa | SC | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Resistant | – | [ |
| 2011 | Diazinone | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Fenobucarbb | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Esfenvaleratea | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Cypermethrina | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Bifenthrina | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Chlorfenapyrg | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Fipronild | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Less effective | – | [ |
| 2011 | Imidaclopridc | Spray | Thailand (Bangkok, Chonburi, Phuket, Krabi) | Effective | – | [ |
| 2015 | d-allethrina | SC | Australia (North Queensland) | Resistant | >130 | [ |
| 2015 | d-allethrina | SC | Australia (Sydney, [NSW]: Auburn) | Resistant | 37 | [ |
| 2015 | d-allethrina | SC | Malaysia (Kuala Lumpur) | Resistant | >130 | [ |
| 2015 | d-allethrina | SC | Thailand (Bangkok, Chiang Mai) | Resistant | >130 | [ |
| 2015 | d-allethrina | SC | Africa (Kenya) | Resistant | 30 | [ |
Abbreviation: SC Surface contact, T Topical application, IT Injection topical application [112]
aPyrethroids
bCarbamates
cNeonicotinoids
dPhenylpyrazoles
eOPs
fSpinosyn
gPyrrole
hChlorinated hydrocarbons
Resistance mechanisms (verified and candidate mechanisms) in bed bugs (Cimex spp.)
| Mechanism |
|
| Insecticide | ||
|---|---|---|---|---|---|
| Behavioral resistance | Candidate mechanism | Candidate mechanism | Pyrethroids | ||
| Physiological resistance | Penetration resistance | Cuticle | Verified by morphological study [ | Candidate mechanism | A broad spectrum of insecticide classes |
| Metabolic resistance | P450s | Verified by RNAi [ | Verified by synergism studies [ | Pyrethroids, OCs, OPs, carbamates, neonicotinoids and pyrroles | |
| Esterases | Verified by synergism studies [ | Candidate mechanism | Carbamates, OPs, pyrroles, neonicotinoids and pyrethroids | ||
| GSTs | Candidate mechanism | Candidate mechanism | OCs, OPs and pyrethroids | ||
| ABC-transporters | Verified by RNAi [ | Candidate mechanism | Pyrethroids, OCs, OPs, carbamates, and neonicotinoids | ||
| Target site insensitivity |
| Verified by QS combined with FCVB [ | Candidate mechanism | Pyrethroids and DDT | |
| Altered AChEs | Candidate mechanism | Candidate mechanism | OPs and carbamates | ||
| Insensitive GABA receptors | Candidate mechanism | Candidate mechanism | Cyclodienes (OCs) and phenylpyrazoles | ||
| Altered nAChRs | Candidate mechanism | Candidate mechanism | Neonicotinoids | ||
| Symbiont-mediated resistance | Candidate mechanism | Candidate mechanism | OPs | ||
Fig. 1Schematic of potential behavioral and physiological changes involved in insecticide resistance in bed bugs. a Susceptible bed bug. b Resistant bed bug. The various forms of resistance act in compounding layers to counteract the effect of the insecticide. For example, direct application of an insecticide such as a pyrethroid may kill the bed bugs; however due to the ‘excito-repellency’ nature of this class of compounds, some bed bugs may avoid insecticide exposure (potential behavioral resistance). If the bed bugs come into contact with an insecticide, the cuticle may be thickened or remodelled by over-expression of cuticular proteins, which will reduce the rate of insecticide penetration (penetration resistance) beyond the cuticular layer. If the insecticides enter the insect, bed bugs can enhance metabolic detoxification (e.g. P450s, esterases, GSTs) to inhibit the insecticidal effect (metabolic resistance). Finally, if the insecticides reach the neurological system to act on the target sites (such as the VGSC), point mutations (e.g. kdr mutations) can reduce the sensitivity of the insecticide target site to the insecticide (target site insensitivity)
Fig. 2kdr mutations in insect voltage-gated sodium channels implicated in pyrethroid/DDT resistance. All information of kdr mutation sites came from Davies & Williamson [150], Zhu et al. [157] and Dang et al. [17, 54]. I, II, III and IV, four homologous repeat transmembrane domains. One asterisk indicates kdr mutations (or putative kdr mutations) identified from both the common bed bug C. lectularius (V419L, valine to leucine; L925I, leucine to isoleucine; putative I936F, isoleucine to phenylalanime) and the tropical bed bug C. hemipterus (putative M918I, methionine to isoleucine; putative L1014F, leucine to phenylalanime). Two asterisks: V410 found in the tobacco budworm Heliothis virescens (F.) and V419 found in C. lectularius are the same residue
Methods used to monitor for insecticide resistance in bed bugs (Cimex spp.)
| Methoda | Advantages | Disadvantages |
|---|---|---|
| Bioassays via dose/concentration-response assays | Provide levels of resistance | Require a susceptible strain, need large numbers of live bed bugs; regardless of mechanism(s) |
| Bioassays via discriminating concentration/dose assays | Standardized (e. g. WHO susceptibility test kits); simple to perform | Provide no information about levels of resistance and type of resistance mechanism(s) (except when using synergists); lack sensitivity |
| Biochemical assays | Require a small sample size; sensitive; provide indirect evidence on specific resistance mechanism(s) | Require sophisticated and costly equipment and the technology which pest managers do not have ready access to; require materials to be kept frozen |
| Molecular assays | Require a small sample size; very sensitive; provide informations on specific resistance mechanism(s); can detect resistance alleles (e. g. | Require specific and costly equipment, high ongoing costs and the technology which pest managers may not have access to; costly reagents, require materials to be kept frozen |
aInformation from Ranson et al. [163], Seong et al. [162] and Dang et al. [16]
Published discriminating doses and susceptibility baselines used to detect insecticide resistance in bed bugs (Cimex spp.)
| Insecticide | Discriminating concentration | Assessment | Susceptibility baseline | Reference | |
|---|---|---|---|---|---|
| LC50/LD50 | LC90(99)/LD90(99) | ||||
|
| |||||
| DDTa | 4% | 5 df | – | – | [ |
| Dieldrina | 0.8% | 2 df | – | – | [ |
| Fenitrothionb | 1% | 5 hf | – | – | [ |
| Malathionb | 5% | 16 hf | – | – | [ |
| Trichlorfonb | 1% | 5 hf | – | – | [ |
| Propoxurc | 0.8% | 24 hf | – | – | [ |
| Permethrind | 0.25% | Cf | – | – | [ |
| Deltamethrind | 0.025% | Cf | – | – | [ |
| Dichlorvosb | – | 24 hf | 2.9 ppm | 5.7 ppm | [ |
| Pirimiphos-methylb | – | 24 hf | 13.5 ppm | 29.8 ppm | [ |
| λ-cyhalothrind | – | 24 hf | 22.2 ppm | 357.7 ppm | [ |
| Permethrind | – | 24 hf | 71.4 ppm | 201.7 ppm | [ |
| Bendiocarbc | – | 24 hf | 47.1 ppm | 95.9 ppm | [ |
| Malathionb | – | 24 hf | 92 ppm | 245 ppm | [ |
| Carbarylc | – | 24 hf | 166.3 ppm | 245 ppm | [ |
| Tetrachlorvinphosb | – | 24 hf | 252 ppm | 472.7 ppm | [ |
| Bendiocarbc | 35.3 M | 48 hf | – | 35.3 M | [ |
| α-cypermethrind | 23.1 M | 48 hf | – | 23.1 M | [ |
| Deltamethrind | 0.06% | Cg | – | – | [ |
| Deltamethrind | 1300 M (30 × LC99) | 24 hf | 3.1 M | 44 M | [ |
| λ-cyhalothrind | – | 24 hf | 2.16 M | 66 M | [ |
| Deltamethrind | 1% | Cf | – | – | [ |
| Deltamethrind | – | 24 hf | 1.4 M | 19.2 M | [ |
| Bendiocarbc | – | 24 hf | 6.5 M | 38.1 M | [ |
| Pirimphos-methylb | – | T, 24 h | 0.11 U | – | [ |
| Imidaclopride | – | T, 24 h | 0.0057 U | – | [ |
| Bendiocarbc | – | T, 24 h | 0.027 U | – | [ |
| Permethrind | – | T, 24 h | 0.00044 U | – | [ |
| Deltamethrind | – | T, 24 h | 0.00057 U | – | [ |
| Deltamethrind | – | 1 hf | 18.1 ppm | 81.8 ppm | [ |
| Deltamethrind | 12 hf | 3.2 ppm | 26 ppm | [ | |
| λ-cyhalothrind | 1 hf | 17.7 ppm | 87 ppm | [ | |
| λ-cyhalothrind | 12 hf | 3.4 ppm | 30 ppm | [ | |
| Deltamethrind | 1300 M (30 × LC99) | 24 hf | – | – | [ |
| Deltamethrind | – | IT, 24 h | 0.00003 U | – | [ |
| β-cyfluthrind | – | IT, 24 h | 0.00004 U | – | [ |
| DDTa | 4% | C f | – | – | [ |
| Dieldrina | 0.8% | C f | – | – | [ |
| Bendiocarbc | 0.1% | C f | – | – | [ |
| Propoxurc | 0.1% | C f | – | – | [ |
| Malathionb | 5% | C f | – | – | [ |
| Fenitrothionb | 1% | C f | – | – | [ |
| Cyfluthrind | 0.15% | C f | – | – | [ |
| Deltamethrind | 0.05% | C f | – | – | [ |
| Permethrind | 0.75% | C f | – | – | [ |
| λ-cyhalothrind | 0.05% | C f | – | – | [ |
| Etofenproxd | 0.5% | C f | – | – | [ |
| Permethrind | 2.56 U (1.6 × LC99) | T, 24/48 h | 0.159 U | 1.65 U | [ |
| Permethrind | 57.6 M | 40 minh | – | – | [ |
| Deltamethrind | 19.6 M | 40 minh | – | – | [ |
| Chlorpyrifosb | 0.2 U (2 × LC99) | T, 24/48 h | 0.03 U | 0.1 U | [ |
| Chlorpyrifosb | 53 M | 40 minh | – | – | [ |
| Malathionb | 0.007% (2 × LC95) | T | – | – | [ |
| Diazinonb | 0.02% (2 × LC95) | T | – | – | [ |
| Trichlorfonb | 1.4% (2 × LC95) | T | – | – | [ |
| Chlorpyrifosb | 0.014% (2 × LC95) | T | – | – | [ |
| Permethrind | 0.03% (2 × LC95) | T | – | – | [ |
| Cypermethrind | 0.00008% (2 × LC95) | T | – | – | [ |
| α-cypermethrind | 0.000001% (2 × LC95) | T | – | – | [ |
| Deltametrhrind | 0.00008% (2 × LC95) | T | – | – | [ |
| λ-cyhalothrind | 0.00005% (2 × LC95) | T | – | – | [ |
| Imidaclopride | 0.0015% (2 × LC95) | T | – | – | [ |
| Acetamipride | 0.0044% (2 × LC95) | T | – | – | [ |
| Deltamethrind | 1300 M (30 × LC99) | 24 hf | – | – | [ |
| Deltamethrind | 0.06 U (100 × LD50) | T, 24 h | 0.0006 U | – | [ |
| Deltamethrind | – | 24 hf | 30 M | – | [ |
| Deltamethrind | – | T | 0.0004 U | – | [ |
| β-cyfuthrind | – | T | 0.00308 U | – | [ |
| Deltamethrind | – | 24 hf | 2.58 M | [ | |
| d-allethrind | 40 mg/mat | 24 hi | – | – | [ |
| Imidaclopride | – | T, 72 h | 0.0023 U | – | [ |
| Acetamipride | – | T, 72 h | 0.0003 U | – | [ |
| Thiamethoxame | – | T, 72 h | 0.0019 U | – | [ |
| Dinotefurane | – | T, 72 h | 0.0145 U | – | [ |
|
| |||||
| DDTa | 2% | 1 hf | – | – | [ |
| α-cypermethrind | 20 M | 72 hj | – | – | [ |
| Permethrind | 200 M | 72 hj | – | – | [ |
| Permethrind | 0.75% | 72 hf | – | – | [ |
| DDTa | 2% | 24 hf | – | – | [ |
| Malathionb | 5% | 16 hf | – | – | [ |
| Propoxurc | 0.8% | 24 hf | – | – | [ |
| Deltamethrind | 0.025% | Cf | – | – | [ |
| Permethrind | 0.25% | Cf | – | – | [ |
| DDTa | 4% | Cf | – | – | [ |
| Dieldrina | 0.8% | Cf | – | – | [ |
| Bendiocarbc | 0.1% | Cf | – | – | [ |
| Propoxurc | 0.1% | Cf | – | – | [ |
| Malathionb | 5% | Cf | – | – | [ |
| Fenitrothionb | 1% | Cf | – | – | [ |
| Cyfluthrind | 0.15% | Cf | – | – | [ |
| Deltamethrind | 0.05% | Cf | – | – | [ |
| Permethrind | 0.75% | Cf | – | – | [ |
| λ-cyhalothrind | 0.05% | Cf | – | – | [ |
| Etofenproxd | 0.5% | Cf | – | – | [ |
| d-allethrind | 40 mg/mat | 24 hi | – | – | [ |
Abbreviations: T topical application, IT injection topical application [113], C continuous exposure, d days, h hours, M mg AI m−2, U μg μL−1 or μg insect−1
aChlorinated hydrocarbons
bOPs
cCarbamates
dPyrethroids
eNeonicotinoids
fSurface contact on filter paper
gSurface contact on Hardboard panels
hSurface contact on glass plates
iSurface contact on mosquito mat
jSurface contact on netting
Synergists as inhibitors of major metabolic detoxification enzymes
| Insecticide detoxification enzymes | Synergists/inhibitorsa |
|---|---|
| Cytochrome P450 monooxygenases (P450s) | PBO, sesamex |
| Esterases | EN16/5–1, DEF, TPP, IBP, K-1, K-2, sesamex, and SV-1 |
| Glutathione S-transferases (GSTs) | DEM, EA and CF |
Abbreviations: DEF S.S.S-tributlyphosphorotrithioate, TPP triphenyl phosphate, IBP S-benzyl diisopropyl phosphorothiolate, K-1 (2-phenyl-4H-1,3,2-benzodioxaphosphorothiolate), K-2 2-phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide, sesamex 5-[1-[2-(2-ethoxyethoxy) ethoxy]ethoxy]-1,3-benzodioxole, SV-1, O,O-diethyl-O-phenyl phosphorothiolate, DEM diethyl maleate, EA ethacrynic acid, CF chlorfenethol
aData sourced from Brogdon & Chan [286], Heong et al. [147] and Lilly et al. [127]
Published molecular markers of genes putatively involved in resistance mechanisms of bed bugs (Cimex spp.)
| Resistance mechanism | Gene | Molecular assay | Primer sequence (5′˗3′) | Reference |
|---|---|---|---|---|
|
| V419 L | PCR and sequencing | F: AACCTGGATATACATGCCTTCAAGG; | [ |
| L925; I936F | PCR and sequencing | F: GGAATTGAAGCTGCCATGAAGTTG; | [ | |
| V419L | AS-PCR | F(V): ATTCCTGGGATCATTCTACCTCg; | [ | |
| L925I | AS-PCR | F(L): ATTATGGGCAGAACAGTGGGTGCCc; | [ | |
| V419L | QS | F: GTCCGTGGCACATGTTGTTCTTCA; | [ | |
| L925I | QS | F: GGTCTATCAGTTTTGAGGTCATTCAG; | [ | |
| M918I; L1014F | PCR and sequencing | F: GGAATTGAAGCTGCCATGAAGTTG; | [ | |
| Penetration resistance | Contig_1766 (CDA) | qRT-PCR | F: TGAATGCTATAAGAATCGTA; | [ |
| Contig_1762 | qRT-PCR | F: TAATGAAGCAAGGCACTA; | [ | |
| Contig_48951 (CPAP) | qRT-PCR | F: GTCCTCAGCACCAATCGT; | [ | |
| Contig_17694 (LCP) | qRT-PCR | F: GCCACTACTATAACAGAG; | [ | |
| Contig_21630 (PCP) | qRT-PCR | F: CCAGATAATTCAAGAGATG; | [ | |
| Contig_24229 | qRT-PCR | F: CGCCAGGGCCGAGGAGTATG; | [ | |
| Contig_24231 | qRT-PCR | F: CGACGATCATCCCCAATACAGTTT; | [ | |
| Contig_24227 | qRT-PCR | F: TTTCTTTTGGCAGCTTTGGTTGTA; | [ | |
| Contig_24230 | qRT-PCR | F: GACTACTACGCCCACCCGAAATAC; | [ | |
| Contig_24228 | qRT-PCR | F: TCCCGCTGTTACCAAGACTCAATG; | [ | |
| Contig_2034 | qRT-PCR | F: TACCGTTAATGCTGCTACACCAA; | [ | |
| Contig_1629 | qRT-PCR | F: AGGCCAGTCCAACACAACCAAC; | [ | |
| Contig_3037 | qRT-PCR | F: ACGGCAGGATGGTCGAAGATTATG; | [ | |
| Contig_2322 | qRT-PCR | F: CGAACCTGCCGGAAGTGACATAAA; | [ | |
| Contig_773 | qRT-PCR | F: GCCGTTGAGCAGCAGCGATAA; | [ | |
| R: CGTGGGGCGGAAGAAGGATT | ||||
| Contig_2220 | qRT-PCR | F: ATGGCACCAGGAGGGGAACTTA; | [ | |
| Contig_1833 | qRT-PCR | F: ACAATTCGGTGGTGCCCCTTTCT; | [ | |
| Contig_820 | qRT-PCR | F: ATCAGCAGCCAAGTCGTAGGAAGC; | [ | |
| Contig_934 | qRT-PCR | F: ACACCACTCCCGTTCCCATCGTC; | [ | |
| Contig_2492 | qRT-PCR | F: CGGTATCTCGGCGAAGGAACAG; | [ | |
| Contig_22513 | qRT-PCR | F: CGACGGAACATACAACTGGGAATA; | [ | |
| Contig_15313 | qRT-PCR | F: ACGGAACCCATCCCGATCCTTAAA; | [ | |
| Contig_02621 | qRT-PCR | F: ACTCCTGAAGTCCAAGCAGCAAGA; | [ | |
| Contig_8158 | qRT-PCR | F: CCAAGCGGTCAAAGCAGCACATTT; | [ | |
| Metabolic resistance | CYP9 | qRT-PCR | N/A | [ |
| CYP6DM2 | qRT-PCR | F: CCCCCTTATGCTACCCGTTTGA; | [ | |
| CYP397A1 | qRT-PCR | F: CTCGGGCTCACCACTCTCAACA; | [ | |
| CYP400A1 | qRT-PCR | F: CCTGCGCGTTCGGAGTCAATA; | [ | |
| Contig_19601 | qRT-PCR | F: TCGGAGGAATGGAAGAAG; | [ | |
| Contig_103 | qRT-PCR | F: AAGTTGTCCTAGAGTGTT; | [ | |
| Contig_22399 | qRT-PCR | F: CGTCATGGTATGGATGGT; | [ | |
| Contig_11345 | qRT-PCR | F: TATTGGAGTCGACAGGGCGTGAAA; | [ | |
| Contig_03764 | qRT-PCR | F: TGTCGACCCAATGATGGCTCTGAA; | [ | |
| Contig_04490 | qRT-PCR | F: GCGAGTCTGGGAAATTGTGCATGAAT; | [ | |
| Contig_04099 | qRT-PCR | F: ATTGGTAACATTGGAGGCCCTGGA; | [ | |
| ClCPR | qRT-PCR | F: TATGCCGCAGAATACGGACAACTC; | [ | |
| [ | CE3959 | qRT-PCR | F: ACGTCTGGAGAAGGGCAACTGAAA; | [ |
| CE21331 | qRT-PCR | F: TCTCACGGGGACGAACTGCCTTAT; | [ | |
| [ | gsts 1 | qRT-PCR | F: AGGAGAGCCAGTTAGATTTATGTT; | [ |
| [ | Contig_1346 | qRT-PCR | F: TGCTCTACATAATTCTGACAT; | [ |
| Contig_08506 | qRT-PCR | F: ATCCTGATGGGCCGAGTAAACCAT; | [ | |
| Contig_02154 | qRT-PCR | F: TTTAGCAACCGATGTGACGCAAGC; | [ | |
| Contig_05955 | qRT-PCR | F: TCACAGCGGTCTTCCTGGATTCTT; | [ | |
| Contig_09403 | qRT-PCR | F: ATGCAGCTCAGTAGGGTCGTCTTT; | [ |
Abbreviation N/A Not applicable, AS-PCR Allele-Specific PCR, QS Quantitative Sequencing qRT-PCR quantitative Real-Time PCR, F Forward primer, R Reverse primer